Association Between Aspirin Use and Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study From the Third National Health and Nutrition Examination Survey

Share
  • Twitter
  • Facebook
  • email
  • StumbleUpon
  • Delicious
  • Google Reader
  • LinkedIn
  • Google Bookmarks

    Oral 28: Association Between Aspirin Use and Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study From the Third National Health and Nutrition Examination Survey

    Paul Mustacchia, MD

    Paul Mustacchia, MD

    Author Insight from Paul Mustacchia, MD, Nassau University Medical Center, East Meadow, NY

    What’s new here and important for clinicians?
    This cross-sectional study was the first human study to investigate the association of aspirin and NAFLD based on the US population from NHANES III

    What do patients need to know?
    Aspirin may be associated with low prevalence of NAFLD in certain population group.

    Read Abstract  Listen to the virtual press briefing

    540_A oral 28

    Author Contact
    Paul Mustacchia, MD, Nassau University Medical Center, East Meadow, NY
    pmustacc@numc.edu

     

    Related Abstracts

    P1441 Association between Caffeine Consumption and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis


    Media Interview Requests:

    To arrange an interview with any ACG experts or abstract authors please contact Jacqueline Gaulin of ACG via email jgaulin@gi.org or by phone at 301-263-9000.

    Share
    • Twitter
    • Facebook
    • email
    • StumbleUpon
    • Delicious
    • Google Reader
    • LinkedIn
    • Google Bookmarks